This country profile provides an overview of Liberia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
2.98 million people received treatment in Liberia in 2019 197k people did not receive treatment in Liberia in 2019
Treatment coverage increased from 68% in 2018 to 84% in 2019.
People needing treatment2.96m
People receiving treatment2.5m
Liberia does not require mass treatment for blinding trachoma.
Treatment coverage increased from 76% in 2018 to 93% in 2019.
Pre-sch and school-aged children needing treatment903k
Pre-school and school-aged children receiving treatment839k
Treatment coverage decreased from 97% in 2018 to 89% in 2019.
School-aged children needing treatment605k
School-aged children receiving treatment539k
Treatment coverage increased from 69% in 2018 to 84% in 2019.
People needing treatment3.18m
People receiving treatment2.66m
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Liberia.